hims glp-1 Full Range of FDA-Approved GLP-1s Available on & Hers Hims & Hers to offer

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Appropriate Dosing Times: Morning time in shower

Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.

Among weight loss products, its Orlistat, the active ingredient in alli, is a lipase inhibitor and works by binding to specific enzymes that break down fats

Does Anthem Blue Cross Blue Shield cover Wegovy

In this study, human umbilical vein endothelial cells (HUVECs), exposed to palmitic acid (PA) to induce endothelial dysfunction, were incubated with metformin, liraglutide or their combination